# ENVOY MEDICAL, INC. (COCH) · Edgar & Edgarette company card

> Envoy Medical (COCH) grew revenue 7.1% in FY2025 to $0 million, operating margin -9241% against a 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity -142% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1840877 · fiscal year ended 2025-12-31 · 4 audited years read · [page](https://www.pops4.com/boards/company/COCH) · [JSON](https://www.pops4.com/boards/company/COCH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $241,000 |
| Revenue growth, 1 year | 7.1% |
| Revenue growth per year | 0.6% |
| Operating margin | -9240.7% (prior year -8558.2%) |
| Net margin | -9857.3% |
| Operating cash flow | −$18M |
| Capital spending | $179,000 |
| Free cash flow | −$18M |
| Cash | $4M |
| Long-term debt | — |
| Total assets | $9M |
| Total equity | −$12M |
| Equity ÷ assets | -142.1% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -141.55 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed auditor change in the last 12 months; liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative (-$18.2M in FY2025); revenue is hard to predict: its 80% range is ±54%

## Edgarette's reading

Exposure: revenue $241K (FY2025). Experience: revenue up 7.1% on the year, up 0.6% a year over 3 years; operating margin -9240.7%, down from -8558.2%. Soundness: equity -142.1% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $135K and $448K next year (method v4.1: its own 3-year record of growth weighed at 40% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $124K to $488K. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, orthopedic, prosthetic & surgical appliances & supplies): operating margin -9240.7% against a 11.0% median; growth 7.1% against 7.5%.

Range logged 2026-10-28, receipt d93ea8ffc2582791, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 4, latest 2026-05-22 ([filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm))
- Item 4.01 Auditor change: 1, latest 2026-03-31 ([filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026037419/0001213900-26-037419-index.htm))
- Item 5.02 Director or officer change: 5, latest 2026-08-27 ([filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026094447/0001213900-26-094447-index.htm))

## Recent filings

- 8-K · filed 2026-10-27 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026112720/0001213900-26-112720-index.htm)
- 8-K · filed 2026-10-16 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026110266/0001213900-26-110266-index.htm)
- 8-K · filed 2026-10-07 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026107434/0001213900-26-107434-index.htm)
- DEF 14A · filed 2026-08-31 · [filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026095756/0001213900-26-095756-index.htm)
- 8-K · filed 2026-08-27 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026094447/0001213900-26-094447-index.htm)
- 8-K · filed 2026-08-10 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840877/000121390026087221/0001213900-26-087221-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001840877.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1840877

## Cite

POPS4, Edgar & Edgarette: ENVOY MEDICAL, INC. (COCH) company card, from the company's own SEC filings, accessed 2026-10-28, https://www.pops4.com/boards/company/COCH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.